Skip to content

Clinical trials

Phase 4 Arthritis, Rheumatoid trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Arthritis, Rheumatoid Phase: Phase 4 Country / region: China Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20101
20124
20131
20141
20152
20161
20181
20192
20201
20213
20223
20231
20241
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status13
Completed8
Recruiting3
Not yet recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Qilu Hospital of Shandong University5
Jiangsu Simcere Pharmaceutical Co., Ltd.4
Chinese SLE Treatment And Research Group3
Peking Union Medical College Hospital2
Pfizer2
Second Affiliated Hospital, Zhejiang University, School of Medicine2
China-Japan Friendship Hospital1
DePuy International1
Jie Chang1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Arthritis, Rheumatoid27
Connective Tissue Diseases2
Lung Diseases, Interstitial2
Myositis2
Osteoarthritis2
Scleroderma, Systemic2
Bone Diseases, Metabolic1
Collagen Diseases1
Hip Dislocation, Congenital1
Osteonecrosis1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.